01/14/2025
4:02 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:19 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1/A | |
01/14/2025
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
5:00 AM | Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2024
6:08 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:41 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
|
12/10/2024
8:42 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
12/10/2024
7:48 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
5:05 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/29/2024
5:06 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/27/2024
5:01 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:30 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
11/20/2024
5:15 AM | Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
11/14/2024
8:03 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:30 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
4:24 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/22/2024
8:02 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form DEF 14A | |
10/16/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
10/16/2024
8:32 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
10/10/2024
4:00 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form PRE 14A | |
10/09/2024
5:04 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/01/2024
5:53 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2024
6:10 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:05 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:06 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/18/2024
3:32 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 424B3 | |
09/17/2024
11:15 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form EFFECT | |
09/09/2024
6:33 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/09/2024
7:00 AM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:48 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/22/2024
5:44 PM | Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
| Form SC 13D | |
08/22/2024
4:23 PM | Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
| Form SC 13D | |
08/21/2024
3:45 PM | Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
6:38 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Lushi Avner (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:43 PM | Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:47 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shiloah Ilan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:48 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Hadar Ilan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
08/15/2024
6:48 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Horenshtein Hadar Mirit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:49 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shirvan Mitchell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:49 PM | Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:50 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Noy Shlomo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
6:54 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Levin Ilan (Reporting)
Moringa Sponsor, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
7:12 PM | Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Potter Leonard (Reporting)
Wildcat Capital Management, LLC (Reporting)
Wildcat Partner Holdings, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
2:22 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form CERT | |
08/15/2024
1:45 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form 8-A12B | |
07/25/2024
3:05 PM | Silexion Therapeutics (Filed by)
Biomotion Sciences (Filed by)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
Moringa Acquisition Corp (Subject)
| Form 425 | |
07/25/2024
3:05 PM | Silexion Therapeutics (Subject)
Biomotion Sciences (Subject)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
Moringa Acquisition Corp (Filed by)
| Form 425 | |
07/17/2024
8:06 AM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form 424B3 | |
07/16/2024
11:15 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form EFFECT | |
07/12/2024
3:21 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form S-4/A | |
07/05/2024
2:49 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form S-4/A | |
06/24/2024
3:49 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form S-4/A | |
05/09/2024
4:18 PM | Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
